Cohbar Stock Price, News & Analysis

CWBR OTC

Company Description

Cohbar (OTC: CWBR) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

CWBR stock has declined 45.3% over the past year. Shares last traded at $0.8800.

This page provides a comprehensive overview of CWBR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-45.34%

Performance 1 year

$0.0

Market Cap

2.9M

Shares outstanding

Cohbar (CWBR) stock last traded at $0.8800. Over the past 12 months, the stock has lost 45.3%.

Latest News

View All

November 27, 2023

-15.44%

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

August 14, 2023

-1.35%

CohBar Reports Second Quarter 2023 Financial Results

earnings

June 5, 2023

-5.59%

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

clinical trial

May 30, 2023

+0.37%

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2023

+223.23%

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

acquisition

November 8, 2022

-10.57%

CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress

earnings

Cohbar has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, clinical trial, acquisition, stock split, conferences. View all CWBR news →

SEC Filings

View All

No SEC filings available for CWBR.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CWBR Company Profile & Sector Positioning

Cohbar (CWBR) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of Cohbar (CWBR)?

The current stock price of Cohbar (CWBR) is $0.88 as of February 7, 2025.